Sub-Saharan African region news, resources and funding for global health researchers
NIH supports a diverse mix of research projects in Sub-Saharan Africa with significant activities in approximately 20 African countries. About a third of the funding supports groundbreaking research and research training on HIV/AIDS and sexually transmitted diseases, including a substantial effort to study mother-to-child transmission of HIV. Around 20 percent funds research on other infectious diseases, ranging from population-based research on malaria, schistosomiasis and leishmaniasis, to molecular research on vectors and parasites. Chronic disease research makes up about 12 percent of the research portfolio, with the remainder devoted to child development, biodiversity, basic research and other studies.
Countries in Region
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Republic of Congo, Côte d’Ivoire, Djibouti, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Libya, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Morocco, Namibia, Niger, Nigeria, Rwanda, São Tomé and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe
NIH Funded Research Impacting Sub-Saharan Africa
- Through grant funding to U.S. universities, NIH facilitates international collaboration in Sub-Saharan Africa in all areas of the biomedical and behavioral sciences.
Fogarty/NIH News
- Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017–2019
Emerging Infectious Diseases, April 2024 - Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
Emerging Infectious Diseases, April 2024 - Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022
Emerging Infectious Diseases, April 2024
-
At 20, the African Journal Partnership Program Enters Young Adulthood
National Library of Medicine’s Musing From the Mezzanine blog, April 3, 2024 -
Experimental Ebola Vaccines Found Safe and Capable of Producing Immune Responses in Healthy Adults
NIAID news, April 3, 2024 -
Linkage Case Management and Posthospitalization Outcomes in People With HIV, co-authored by Fogarty grant recipient Saidi Kapiga
JAMA, March 6, 2024 -
The HIV-2 proviral landscape is dominated by defective proviruses, co-authored by Fogarty grant recipient Roger Shapiro and Fogarty trainee Catherine K. Koofhethile
AIDS, March 1, 2024 -
A researcher-exchange programme made me a better doctor at home and abroad – profile of former Fogarty Global Health Fellow Caleb Skipper
Nature, February 12, 2024 -
Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans, co-authored by Fogarty grant recipients Bruce Ovbiagele and Mayowa O. Owolabi, Fogarty trainees Onoja Akpa, Reginald Obiako, Godwin O. Osaigbovo, Abiodun Adeoye, Okechukwu S. Ogah, Godwin Ogbole, and Akinkunmi Okekunle, and National Human Genome Research Institute’s Charles Rotimi
Genome Medicine, February 5, 2024 -
Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana, co-authored by Fogarty grant recipients Roger Shapiro, Joseph Makhema, and Shahin Lockman, Fogarty Emerging Global Leader Sikhulile Moyo, and Fogarty trainees Mompati Mmalane and Simani Gaseitsiwe
AIDS, February 1, 2024
Funding/Training Opportunities
U.S. Government Resources
Other Resources
Fogarty Contact
Stacy Wallick, MPH
Regional Program Director, Sub-Saharan Africa
Division of International Relations
Fogarty International Center
National Institutes of Health
Building 31 Room B2C11
Bethesda, MD 20892-2220
Telephone: 301-496-2091
FAX: 301-480-3414
Email (preferred):
Stacy.Wallick@nih.gov
Updated April 19, 2024